Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
October 1st, 2019
This protocol integrated near-infrared spectroscopy into conventional cardiopulmonary exercise testing to identify the involvement of the cerebral hemodynamic response in exercise intolerance in patients with heart failure.
The degree of cerebral tissue saturation in heart failure has been proven to reflect functional capacity and disease severity and has potential prognostic value. Radon monitoring during exercise testing has clinical value. Cerebral tissue oxygen saturation measured by NIRS is simple and convenient.
This protocol-integrated NIRS into conventional CPET to increase the value of exercise testing in patients with heart failure. Demonstrating the procedure will be Yu Chen Liu, a technician from our laboratory. To begin this procedure, clean the patient's forehead twice with an alcohol pad to remove sweat and dirt from the skin.
Obtain large NIRS sensors in which the distance between the emitter and the detector is five cm and place the sensors on the forehead, bilaterally. Ensure that the sensors are securely attached. Next apply EKG electrodes to the anterior chest, bilateral acromioclavicular joints, and low back.
Have the patient sit on the bicycle ergometer and place the armband of the sphygmomanometer on them. Then, wear the mask of gas analysis for the patient place the sensors for the pulse oximeter on the patient's index finger. First, tell the patient to rest for at least two minutes to obtain a stable baseline value including the cerebral tissue oxygen saturation and respiratory exchange ratio.
Next, have the patient complete the warm-up stage on the cycle ergometer at a work rate of 10 watts for one minute. Increase the rate by 10 watts per minute then ask the patient to pedal at around 60 rpm until he fails to keep up with a cadence of over 50 rpm despite strong encouragement. Automatically average the cerebral tissue oxygen saturation value every second from the data scanned at a frequency of 100 Hz.Automatically measure the blood pressure every two minutes with the sphygmomanometer.
Analyze the gas component, breath-by-breath, including the oxygen uptake and the end-tidal carbon dioxide pressure. Then, have the patient complete the recovery stage at a work rate of zero watts for two to six minutes. In this study, both heart failure patients and healthy controls underwent cardiopulmonary exercise testing that incorporates cerebral tissue oxygen saturation monitoring by NIRS.
The cerebral tissue oxygen saturation values are seen to briefly be significantly lower in the heart failure group than in the control group. In the heart failure group, the cerebral tissue oxygen saturation at rest and at peak are linearly correlated with Brain Natriuretic Peptide, the peak oxygen uptake, and the oxygen uptake efficiency slope. Notably, the cerebral tissue oxygen saturation at rest is determined by the partial pressure of the end-tidal carbon dioxide at rest, hemoglobin, and mean arterial pressure at rest.
The procedure is simple and convenient. Patients with low cerebral saturation index warrent high medical attention. Integration of NIRS into CPET helps delineate the involvement of cerebral hemodynamic suppression causing exercise intolerance in patients with heart failure.
Besides its prognostic value, it needs longitudinal research to confirm.
View the full transcript and gain access to thousands of scientific videos
Overview
This protocol integrated near-infrared spectroscopy into conventional cardiopulmonary exercise testing to identify the involvement of the cerebral hemodynamic response in exercise intolerance in patients with heart failure. The degree of cerebral tissue saturation has been shown to reflect functional capacity and disease severity.
Key Study Components
Area of Science
- Neuroscience
- Cardiology
- Exercise Physiology
Background
- Cerebral tissue oxygen saturation is a key indicator of brain health.
- Heart failure patients often experience exercise intolerance.
- Near-infrared spectroscopy (NIRS) is a non-invasive method for measuring oxygen saturation.
- Integrating NIRS with cardiopulmonary exercise testing (CPET) can enhance diagnostic capabilities.
Purpose of Study
- To assess the cerebral hemodynamic response during exercise in heart failure patients.
- To improve the prognostic value of exercise testing.
- To demonstrate the procedure for clinical application.
Methods Used
- Near-infrared spectroscopy (NIRS) was used to measure cerebral tissue saturation.
- Conventional cardiopulmonary exercise testing (CPET) was performed.
- Patient preparation included cleaning the forehead with an alcohol pad.
- Data were collected and analyzed to evaluate exercise intolerance.
Main Results
- Cerebral tissue saturation correlated with functional capacity.
- Exercise intolerance was linked to altered cerebral hemodynamics.
- NIRS provided valuable insights during CPET.
- The protocol demonstrated feasibility for clinical use.
Conclusions
- Integrating NIRS into CPET enhances the assessment of heart failure patients.
- Cerebral hemodynamic responses are critical in understanding exercise limitations.
- This approach has potential for improving patient management and outcomes.
Frequently Asked Questions
Executive Industry Relevance
Integrating cerebral tissue oxygen saturation monitoring via NIRS into cardiopulmonary exercise testing (CPET) addresses a critical gap in evaluating exercise intolerance in heart failure patients. This approach enhances predictive confidence in functional capacity assessment and supports risk-adjusted portfolio decisions in early translational research. The method enables more precise stratification of disease severity, informing both target validation and mechanistic de-risking in cardiovascular R&D pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of the link between cerebral hemodynamics and exercise intolerance in heart failure.
- Supports biological de-risking by quantifying brain oxygenation as a functional biomarker.
- Facilitates predictive confidence in target selection for interventions addressing cerebral hypo-oxygenation.
Screening & Assay Development
- Prepares validated physiological readouts for downstream translational studies.
- Standardizes measurement of cerebral tissue saturation for reproducible quantitative outputs.
- Enables reliable comparison of intervention effects on cerebral oxygenation during exercise.
Translational & Preclinical Research
- Aligns with disease-relevant endpoints by linking SctO2 to established prognostic markers.
- Supports continuity from discovery through preclinical validation by integrating functional and hemodynamic data.
- Provides mechanistic de-risking for candidate therapies targeting cerebral perfusion in heart failure.
Pipeline & Workflow Integration
This protocol positions NIRS-based cerebral saturation monitoring as a bridge from early discovery to translational research in cardiovascular drug development.
- Discovery Biology: Quantifies cerebral oxygenation to clarify mechanisms underlying exercise intolerance.
- Screening: Delivers reproducible, quantitative SctO2 outputs for intervention assessment.
- Analytics: Provides continuous, high-frequency measurements for robust statistical analysis of physiological responses.
- Translational Research: Links functional readouts to clinical prognostic markers, supporting biomarker alignment.
- Enterprise Reuse: Establishes a scalable, non-invasive monitoring capability for diverse cardiovascular models.
Operational & Enterprise Impact
- Scientific Value: Improves predictive confidence and target validation by integrating functional and hemodynamic endpoints.
- Operational Value: Standardizes and streamlines physiological monitoring within exercise testing workflows.
- Strategic Value: Enables more informed go/no-go decisions and reduces late-stage biological risk in cardiovascular portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization of candidates targeting cerebral and systemic hemodynamics.
Implementation Considerations
- Requires expertise in physiological monitoring and exercise testing protocols.
- Needs access to NIRS instrumentation and integrated CPET platforms.
- Demands cross-team standardization of sensor placement and data acquisition.
- Adaptation may be needed for different patient populations or disease models.
- Longitudinal validation is necessary to confirm prognostic value across studies.
